SCHEMBL1632085

SCHEMBL1632085

CN1CCN(c2cc(-c3cccc4cnc(Nc5ccc(S(N)(=O)=O)cc5)nc34)ccn2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMG1 Q96Q15 4/20 0.62
MTOR P42345 3/20 0.62
JAK2 O60674 3/20 0.57
BRD4 O60885 2/20 0.57
CDK1 P06493 2/20 0.50
CDK2 P24941 2/20 0.50
EGFR P00533 2/20 0.49
JAK3 P52333 1/20 0.47
AURKA O14965 2/20 0.47
IKBKB O14920 2/20 0.46
CDK4 P11802 1/20 0.46
CLK2 P49760 1/20 0.45
CLK3 P49761 1/20 0.45
DYRK1A Q13627 1/20 0.45
BMPR2 Q13873 1/20 0.45
FGFR1 P11362 1/20 0.45
KDR P35968 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724192 0.90 SMG1 (0.54) SMG1MTORJAK2BRD4CDK1
SCHEMBL1631108 0.90 SMG1 (0.70) SMG1MTORJAK2CDK1CDK2
SCHEMBL1633192 0.88 JAK2 (0.55) SMG1MTORJAK2BRD4CDK1
SCHEMBL1632115 0.85 JAK2 (0.66) JAK2BRD4CDK1CDK2EGFR
SCHEMBL1633189 0.85 SMG1 (0.50) SMG1MTORJAK2BRD4CDK1
SCHEMBL1633026 0.84 SMG1 (0.59) SMG1MTORJAK2CDK1CDK2
SCHEMBL1860937 0.84 SMG1 (0.59) SMG1MTORJAK2CDK1CDK2
SCHEMBL1632522 0.81 DKK1 (0.51) CDK1CDK2IKBKBCA12CA1
SCHEMBL1633187 0.81 MTOR (0.60) SMG1MTORJAK2BRD4CDK2
SCHEMBL1631949 0.80 DKK1 (0.50) CDK1CDK2AURKAIKBKBCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed